France· FR:61646128
INSUMAN IMPLANTABLE 400 UI/ml, solution pour perfusion
A medicinal product containing insuline humaine recombinante neutre, registered in France by SANOFI AVENTIS (ALLEMAGNE).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- INSULINE HUMAINE RECOMBINANTE NEUTRE
- Manufacturer
- SANOFI AVENTIS (ALLEMAGNE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009585748491 flacon(s) en verre de 10 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Insuline humaine recombinante neutre in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IrelandInsuman Implantable 400 IU/ml solution for infusionSanofi-Aventis Deutschland GmbH
- NetherlandsInsuman Implantable 400 IE/ml oplossing voor infusieSanofi-Aventis Deutschland GmbH
- CzechiaACTRAPIDNovo Nordisk A/S, Bagsvaerd
- FinlandActrapidNovo Nordisk A/S
- PolandActraphane 30Novo Nordisk A/S
- GermanyBerlinsulin H Basal PenLilly Deutschland Gmbh
- United StatesAFREZZAMannkind Corporation
- United KingdomActrapid 100units/ml solution for injection 10ml vialsNovo Nordisk Ltd
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Huminsulin Basal Kwikpen, Huminsulin Basal Kwikpen Lilly
- Belgium · Humuline 30/70 Cartridge, Humuline Nph Cartridge
- Bulgaria · Humulin M3 (Mixture 3), Хумулин N
- Cyprus · Humulin M3
- Czechia · Humulin M3 (30/70) Cartridge, Humulin M3 (30/70) Kwikpen
- Germany · Huminsulin Basal (Nph), Huminsulin Basal (Nph) Kwikpen
- Denmark · Humulin Nph, Humulin Nph Kwikpen
- Estonia · Humulin N, Humulin N Kwikpen
- Spain · Humulina 30:70, Humulina 30:70 Kwikpen
- United Kingdom (Northern Ireland) · Humulin I (Isophane), Humulin I Kwikpen (Isophane)
- Greece · Humulin M3, Humulin M3 Kwikpen
- Croatia · Humulin M3, Humulin N
- Hungary · Humulin M3 (30/70), Humulin N
- Ireland · Humulin I (Isophane), Humulin I Kwikpen (Isophane)
- Italy · Humulin 30/70 (Miscela), Humulin I (Isofano)
- Lithuania · Humulin N, Humulin N Kwikpen
- Luxembourg · Humuline 30/70 Cartridge, Humuline Nph Cartridge
- Latvia · Humulin N, Humulin N Kwikpen
- Malta · Humulin I (Isophane), Humulin M3 (Mixture 3)
- Netherlands · Humuline 30/70 Patroon, Humuline Nph Kwikpen
- Portugal · Humulin M3 (Mistura M3), Humulin Nph
- Romania · Humulin M3, Humulin M3 Kwikpen
- Sweden · Humulin Nph, Humulin Nph Kwikpen
- Slovenia · Humulin M3, Humulin M3 Kwikpen
- Slovakia · Humulin M3 (30/70) Cartridge, Humulin M3 (30/70) Kwikpen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c91296d2-78d1-40ab-892d-cca6643fa794 GET /v1/drugs/c91296d2-78d1-40ab-892d-cca6643fa794?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "61646128",
"date_amm": "2013-09-19",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/97/030",
"substance": "INSULINE HUMAINE RECOMBINANTE NEUTRE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution pour perfusion",
"voies_administration": "intrapéritonéale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about insuline humaine recombinante neutre.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.